Komoto Junichi, Yamada Taro, Watanabe Kikuko, Takusagawa Fusao
Department of Molecular Biosciences, University of Kansas, 1200 Sunnyside Avenue, Lawrence, Kansas 66045-7534, USA.
Biochemistry. 2004 Mar 2;43(8):2188-98. doi: 10.1021/bi036046x.
Prostaglandin H(2) (PGH(2)) formed from arachidonic acid is an unstable intermediate and is efficiently converted into more stable arachidonate metabolites (PGD(2), PGE(2), and PGF(2)) by the action of three groups of enzymes. Prostaglandin F synthase (PGFS) was first purified from bovine lung and catalyzes the formation of 9 alpha,11 beta-PGF(2) from PGD(2) and PGF(2)(alpha) from PGH(2) in the presence of NADPH. Human PGFS is 3 alpha-hydroxysteroid dehydrogenase (3 alpha-HSD) type II and has PGFS activity and 3 alpha-HSD activity. Human lung PGFS has been crystallized with the cofactor NADP(+) and the substrate PGD(2), and with the cofactor NADPH and the inhibitor rutin. These complex structures have been determined at 1.69 A resolution. PGFS has an (alpha/beta)(8) barrel structure. The cofactor and substrate or inhibitor bind in a cavity at the C-terminal end of the barrel. The cofactor binds deeply in the cavity and has extensive interactions with PGFS through hydrogen bonds, whereas the substrate (PGD(2)) is located above the bound cofactor and has little interaction with PGFS. Despite being largely structurally different from PGD(2), rutin is located at the same site of PGD(2), and its catechol and rhamnose moieties are involved in hydrogen bonds with PGFS. The catalytic site of PGFS contains the conserved Y55 and H117 residues. The carbonyl O(11) of PGD(2) and the hydroxyl O(13) of rutin are involved in hydrogen bonds with Y55 and H117. The cyclopentane ring of PGD(2) and the phenyl ring of rutin face the re-side of the nicotinamide ring of the cofactor. On the basis of the catalytic geometry, a direct hydride transfer from NADPH to PGD(2) would be a reasonable catalytic mechanism. The hydride transfer is facilitated by protonation of carbonyl O(11) of PGD(2) from either H117 (at low pH) or Y55 (at high pH). Since the substrate binding cavity of PGFS is relatively large in comparison with those of AKR1C1 and AKR1C2, PGFS (AKR1C3) could catalyze the reduction and/or oxidation reactions of various compounds over a relatively wide pH range.
由花生四烯酸形成的前列腺素H(2)(PGH(2))是一种不稳定的中间体,通过三组酶的作用可有效地转化为更稳定的花生四烯酸代谢物(PGD(2)、PGE(2)和PGF(2))。前列腺素F合酶(PGFS)最初是从牛肺中纯化出来的,在NADPH存在的情况下,它催化从PGD(2)形成9α,11β-PGF(2)以及从PGH(2)形成PGF(2)(α)。人PGFS是II型3α-羟基类固醇脱氢酶(3α-HSD),具有PGFS活性和3α-HSD活性。人肺PGFS已与辅因子NADP(+)和底物PGD(2),以及辅因子NADPH和抑制剂芦丁一起结晶。这些复合物结构已在1.69 Å分辨率下确定。PGFS具有(α/β)(8)桶状结构。辅因子和底物或抑制剂结合在桶状结构C末端的一个腔内。辅因子深深地结合在腔内,并通过氢键与PGFS有广泛的相互作用,而底物(PGD(2))位于结合的辅因子上方,与PGFS几乎没有相互作用。尽管芦丁在结构上与PGD(2)有很大不同,但它位于PGD(2)的同一位置,其儿茶酚和鼠李糖部分参与与PGFS的氢键形成。PGFS的催化位点包含保守的Y55和H117残基。PGD(2)的羰基O(11)和芦丁的羟基O(13)参与与Y55和H117的氢键形成。PGD(2)的环戊烷环和芦丁的苯环面向辅因子烟酰胺环的re侧。基于催化几何结构,从NADPH到PGD(2)的直接氢化物转移将是一种合理 的催化机制。氢化物转移通过PGD(2)的羰基O(11)从H117(在低pH下)或Y55(在高pH下)的质子化而促进。由于与AKR1C1和AKR1C2相比,PGFS的底物结合腔相对较大,PGFS(AKR1C3)可以在相对较宽的pH范围内催化各种化合物的还原和/或氧化反应。